Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Research Use Only - Important Disclaimer

All products listed on this website are intended for laboratory research use only and are not for human consumption, medical, veterinary, or household use. These products should only be handled by qualified professionals. We do not provide any dosage information, and the products must not be used as food additives, drugs, cosmetics, or for any other inappropriate applications. By purchasing, you acknowledge and agree to these terms.

Vial

Pramlintide

Synthetic Amylin AnalogFor research use only
View

Pramlintide is a synthetic analog of human amylin, a beta-cell co-secreted peptide with insulin. In research settings it’s used to study postprandial glucose co…

Half-life

~45–60 minutes (SC); pharmacodynamic effects ~2–3 hours

Delivery

Subcutaneous injection immediately prior to major meals (separate site from insulin).

Suggested dosage

Not specified

Usage

Investigated as an adjunct to mealtime insulin to model reductions in postprandial hyperglycemia and appetite, and to explore amylin physiology in metabolic studies.

Mechanism of action

Activates amylin receptors to slow gastric emptying, suppress inappropriate postprandial glucagon secretion, and enhance satiety—thereby reducing postprandial glucose excursions.

Benefits (4)

  • Reduces postprandial glucose excursions
  • Decreases glucagon surge after meals
  • Slows gastric emptying
  • May reduce appetite and caloric intake

Side effects (5)

  • Nausea, vomiting, abdominal discomfort
  • Decreased appetite
  • Injection-site reactions
  • Hypoglycemia when used with insulin (requires mealtime insulin dose reduction)
  • Boxed warning: severe insulin-induced hypoglycemia risk, especially within 3 hours post-dose
No purchase links available